The HPV vaccine reduces cervical cancer by almost 90%, according to the first data of a study published in The Lancet. British researchers say the vaccine saves lives, and immunized people could take the Pap test less often.
A study by scientists in the UK looked at what happened after the HPV vaccine was introduced in 2008 for girls aged 11 to 13 in England. The girls are over 24 years old now.
According to the BBC, the study showed both a decrease in the incidence of precancerous lesions caused by the Human Papilloma Virus and an 87% reduction in cases of cervical cancer.
Thus, the anti-HPV vaccination program in Great Britain, which in 2019 also targeted boys, prevented the occurrence of 450 cases of cancer and over 17 thousand cases of precancerous lesions.
The researchers categorized these results as historical and say that the Pap test, which is done every 3 or even 5 years in the UK, could be performed less often by vaccinated people. Romania has the highest incidence and mortality rate caused by cervical cancer caused by the Human Papilloma Virus.
The Ministry of Health has extended free vaccination for girls up to the age of 18, compared to 14 when it was originally, and intends the vaccination program to target boys as well. The state has purchased 40,000 doses of HPV vaccine this year, but there are still many children on waiting lists at family doctors’ offices.
Sursa foto: Unsplash / Markus Spiske
Read also: UK is the first country in the world to approve Molnupiravir, Merck’s anti-COVID pill | AUDIO
–
